Trade Summary

2 days ago, Okey Stephanie, serving as Dir at Crinetics Pharmaceuticals, Inc. (CRNX), sold 6,900 shares at $35.67 per share, for a total transaction value of $246,142.80. Following this transaction, Okey Stephanie now holds 6,400 shares of CRNX.

This sale represents a 51.88% decrease in Okey Stephanie's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 at 5:23 PM ET, 1 day after the trade was made.

Crinetics Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.